USPTO trademark

IMMODULON

RegisteredUSPTOWord markClass 5Class 42Class 44

"IMMODULON" is a word mark owned by Immodulon Therapeutics Limited, filed at the USPTO on March 25, 2019. It is registered and covers classes 5, 42 and 44.

View Immodulon Therapeutics Limited portfolioGet this data via the API
Official USPTO record
IMMODULON trademark as filed
As filed with the USPTO
Status
Registered
Since November 23, 2021
Filed
March 25, 2019
Registered
November 23, 2021
Expires
Not recorded
Application no.
88354623
Registration no.
6564939
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns IMMODULON

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Immodulon Therapeutics Limited

London, United Kingdom

4 trademarks in the portfolioView company

Representative

Alexandra MacKay

Stites & Harbison, PLLC

Goods and services

What the mark covers

The products and services IMMODULON is filed for, grouped by Nice class.

  • Vaccines; immune modulators, namely, pharmaceutical preparations for treatment of immune system related diseases, disorders, and dysregulation; vitamins and vitamin preparations

  • Scientific and technological services and research and design relating thereto, namely, research and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research services, namely, research relating to immune system related diseases and disorders; clinical research in the field of medical science, namely, medical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biological products, medical apparatus, devices and instruments, namely, pharmaceutical drug development services; supply of information in the area of laboratory technology, namely, providing technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portals, namely, providing scientific information regarding immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; scientific consultancy, namely, consulting services in the field of the research and development of immunotherapy products, namely, pharmaceutical preparations for the treatment of immune system related disease, disorder, and dysregulation; consultancy and research in the fields of science and technology, namely, research in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic services, namely, laboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technology, namely, providing an on-line computer database in the field of medical and scientific research of immune dysregulation

  • Medical and therapeutic services, namely, treatment of patients with immuno disorders; medical, hygienic and beauty care for human beings; provision of medical information; advisory services relating to medical services, preparations and apparatus, namely, providing medical information, consultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of health, namely, providing an on-line computer database featuring information regarding health and nutrition

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Registered-principal register
  2. 1(b) basis deleted; proceed to registration
  3. Case assigned to intent to use paralegal
  4. Notice of allowance cancelled
  5. Teas delete 1(b) basis received
  6. Notice of approval of extension request e-mailed
  7. Sou extension 1 granted
  8. Sou extension 1 filed
  9. Sou teas extension received
  10. Noa e-mailed - sou required from applicant

10 earlier steps on the official record.

FAQ

About IMMODULON

Who owns the trademark "IMMODULON"?

The USPTO trademark "IMMODULON" (application 88354623) is owned by Immodulon Therapeutics Limited.

What is the status of "IMMODULON"?

Its status at the USPTO is: registered.

When was "IMMODULON" registered?

It was registered on November 23, 2021.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull IMMODULON and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a60-f66a-74fe-b9f2-1a742fceb27d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a60-f66a-74fe-b9f2-1a742fceb27d",
  "object": "trademark",
  "mark_text": "IMMODULON",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "88354623",
  "filing_date": "2019-03-25",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "Immodulon Therapeutics Limited",
      "entity_id": "ent_019ebad2-d08e-742b-ad70-e9c1cfa51d44"
    }
  ]
}